Title |
Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?
|
---|---|
Published in |
Current Cardiology Reports, April 2017
|
DOI | 10.1007/s11886-017-0856-8 |
Pubmed ID | |
Authors |
Evangelos C. Rizos, Moses S. Elisaf |
Abstract |
Omega-3 fatty acids are increasingly used for the protection of cardiovascular disease. The main but not the sole mechanism of action is the reduction of triglyceride levels. In this review, we summarize the effect of omega-3 supplements on all-cause and cardiovascular mortality, myocardial infarction, and stroke from the relevant randomized controlled trials. Twenty-one randomized controlled trials assessed omega-3 supplementation on mortality and cardiovascular-related outcomes. From these studies, as well as from the relevant meta-analyses, we found that omega-3 supplements do not exert a consistent benefit for cardiovascular protection. There is uncertainty of a clear profit from omega-3 supplementation in cardiovascular disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 4 | 27% |
United States | 3 | 20% |
Mexico | 1 | 7% |
Unknown | 7 | 47% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 67% |
Practitioners (doctors, other healthcare professionals) | 3 | 20% |
Scientists | 2 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 2% |
United States | 1 | 2% |
Unknown | 55 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 18% |
Student > Master | 7 | 12% |
Other | 7 | 12% |
Researcher | 7 | 12% |
Student > Ph. D. Student | 4 | 7% |
Other | 9 | 16% |
Unknown | 13 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 16% |
Biochemistry, Genetics and Molecular Biology | 8 | 14% |
Agricultural and Biological Sciences | 6 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 9% |
Nursing and Health Professions | 4 | 7% |
Other | 6 | 11% |
Unknown | 19 | 33% |